MARKET

ENTA

ENTA

Enanta Pharmaceuticals Inc
NASDAQ
7.49
+0.35
+4.90%
Pre Market: 7.22 -0.27 -3.60% 07:25 02/19 EST
OPEN
7.14
PREV CLOSE
7.14
HIGH
7.59
LOW
6.92
VOLUME
348
TURNOVER
0
52 WEEK HIGH
17.80
52 WEEK LOW
4.710
MARKET CAP
159.78M
P/E (TTM)
-1.5127
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ENTA last week (0210-0214)?
Weekly Report · 2d ago
Enanta Pharmaceuticals (ENTA) Moves to Buy: Rationale Behind the Upgrade
NASDAQ · 4d ago
Enanta Pharmaceuticals, Inc.'s (NASDAQ:ENTA) Shares Bounce 55% But Its Business Still Trails The Industry
Simply Wall St · 5d ago
Thursday 2/13 Insider Buying Report: BPRN, ENTA
NASDAQ · 5d ago
Enanta Pharmaceuticals (ENTA) Receives a Buy from Evercore ISI
TipRanks · 6d ago
Enanta Pharmaceuticals Advances in Virology and Immunology
TipRanks · 6d ago
Enanta CEO buys $256K in common stock
TipRanks · 6d ago
Based on the provided financial report, the title of the article is: "ENANTA PHARMACEUTICALS, INC. Quarterly Report (Form 10-Q) for the quarterly period ended December 31, 2024
Press release · 6d ago
More
About ENTA
Enanta Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of small molecule drugs with an emphasis on indications in virology and immunology. The Company’s clinical programs are focused on respiratory syncytial virus (RSV) and its earlier-stage immunology pipeline aims to develop treatments for inflammatory diseases by targeting key drivers of the type 2 immune response, including receptor tyrosine kinase (KIT) and STAT6 inhibition. The Company has two clinical-stage product candidates for RSV, which are zelicapavir and EDP-323. Glecaprevir, a protease inhibitor discovered by the Company, is part of one of the treatment regimens for curing chronic hepatitis c virus (HCV) infection and is sold by AbbVie in various countries under the tradenames MAVYRET (U.S.) and MAVIRET (ex-U.S.) (glecaprevir/pibrentasvir). The Company also has development programs in virology for SARS-CoV-2 and Hepatitis B virus.

Webull offers Enanta Pharmaceuticals Inc stock information, including NASDAQ: ENTA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ENTA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ENTA stock methods without spending real money on the virtual paper trading platform.